BPA Call HHSN263200000053507B-HHSN27400002

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Peprotech Inc., a privately-owned biotechnology company. The $4,205 contract is for the delivery of drugs and biologicals, with a performance period ending on September 16, 2012. Peprotech Inc. is a manufacturer of cytokines and other biological products, and has received several prior federal contract awards from...

New England Peptide LLC was awarded a Blanket Purchase Agreement (BPA) call contract by an unnamed U.S. government agency to provide Custom Peptide Synthesis services at the Tier Two level. Performance will take place in Bethesda, Maryland. The start date for this contract was July 16, 2009, with an unknown end date and pricing determined on an Other basis. This BPA call contract was issued under an indefinite-delivery/indefinite-quantity vehicle and does not appear to contain any set-aside...

Peprotech Inc. was awarded an indefinite delivery/indefinite quantity (IDIQ) blanket purchase agreement (BPA) call by the National Institutes of Health (NIH) to provide biological materials and blood/blood products in support of NIH's biomedical research programs. As the prime contractor, Peprotech will deliver these commodities from its Bethesda, Maryland facility on an as-needed basis over an open-ended period of performance beginning in December 2008. The contract pricing structure utilizes...

The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...

This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of "TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES." The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...

This is a $11,590 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Peptide 2.0 Inc., a minority-owned small business, for the provision of custom peptides. The contract has a period of performance ending on March 25, 2015. Peptide 2.0 Inc., also doing business as Peptide 20 Inc., is a for-profit organization that specializes in custom peptide synthesis, production, and research, and has received several previous contract awards from the NIH and the U.S....

The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), awarded a $7,900.00 Firm Fixed Price purchase order contract to Pepscan Presto B.V., a foreign-owned for-profit organization, for the provision of PEPCHIPTM KINOMICS SLIDES. This contract, with a performance period ending on September 30, 2015, did not have a set-aside designation. Pepscan Presto B.V. is an experienced provider of peptide-based products and services,...

This is a $92,322 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Proimmune, Inc., a small business contractor, to provide services to the FDA's Center for Biologics Evaluation and Research (CBER), Office of Division of Plasma Protein Therapeutics' (DPPT) / Hemostasis Branch (HB). The contract is for determining a reliable and comprehensive identification of FVIII-derived peptides to compare processing by antigen presenting cells between wild-type and...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and related products. The contract is valued at $7,975.75 and requires the delivery of custom peptides of the Zaire Ebola virus glycoprotein, as individual and pooled aliquots, with quality control via liquid chromatography-mass...